Biosplice Therapeutics Stock Price, Funding, Valuation, Revenue ...

Apr 15, 2021  · Funding, Valuation & Revenue. 6 Fundings. Biosplice Therapeutics has raised $561.5M over 6 rounds.. Biosplice Therapeutics's latest funding round was a Series B for $120M on April 15, 2021.. Biosplice Therapeutics's valuation in August 2018 was $12,000M.


Install CouponFollow Chrome Extension   CouponFollow Extension

$561
OFF

Biosplice Therapeutics Stock Price, Funding, Valuation, Revenue ...

6 days from now

Apr 15, 2021  · Funding, Valuation & Revenue. 6 Fundings. Biosplice Therapeutics has raised $561.5M over 6 rounds.. Biosplice Therapeutics's latest funding round was a Series B for $120M on April 15, 2021.. Biosplice Therapeutics's valuation in August 2018 was $12,000M.

cbinsights.com

$120
OFF

Biosplice Therapeutics Closes $120 Million In Equity Financing To ...

6 days from now

Apr 15, 2021  · New investors include Eventide, aMoon, SymBiosis II, Sands Capital and VeritionProceeds to support Biosplice’s clinical development of lorecivivint, its Phase 3 …

yahoo.com

$95
OFF

Biosplice Therapeutics - Company Profile - Tracxn

6 days from now

6 days ago  · Biosplice Therapeutics ranks 314th among 3096 active competitors. 1083 of its competitors are funded while 696 have exited. Overall, Biosplice Therapeutics and its competitors have raised over $95.3B in funding across 4322 funding rounds involving 9692 investors. There are 5 private unicorns, 440 public and 256 acquired companies in the entire competition set.

tracxn.com

$120
OFF

Biosplice Therapeutics Closes $120 Million In Equity Financing To ...

6 days from now

SAN DIEGO, April 15, 2021 (GLOBE NEWSWIRE) -- Biosplice Therapeutics, Inc. (“Biosplice”), a clinical-stage biotechnology company pioneering therapeutics based on alternative pre-mRNA …

biospace.com

$4.62
OFF

Biosplice Stock $4.62 | How To Buy, Valuation, Stock Price, IPO

6 days from now

Nov 6, 2024  · Since it is not publicly listed, there is no Biosplice stock symbol or Biosplice ticker symbol assigned for Biosplice. Private companies typically reserve a stock symbol up to two years prior to an IPO, and disclose this when they file a Form S-1 with the Security Exchange Commission when they start the IPO process.

notice.co

$140
OFF

Haisco To Pay $140M To Get The Ball Rolling On Biosplice's Phase 3 ...

6 days from now

Sep 15, 2021  · Biosplice signed a similar agreement with Samil Pharmaceutical for $70 million in aggregate value in April. Samil got the right to develop and commercialize the treatment in …

fiercebiotech.com

$12
OFF

After Reaching A High With $12B Valuation, Biosplice Lays Off Staff …

6 days from now

Feb 8, 2022  · After reaching a $12 billion valuation in 2018, Biosplice appears to be falling back down to Earth, and its workforce is taking the brunt. The company is laying off 41 workers, according to a ...

fiercebiotech.com

$220
OFF

Biosplice’s High Valuation Turned Heads. Layoffs Now Raise ... - STAT

6 days from now

Feb 8, 2022  · In 2016, Biosplice, then known as Samumed, made headlines by raising $220 million at a $6 billion valuation; two years later, it raised another $438 million at a $12.8 billion …

statnews.com

FAQs about Biosplice Therapeutics Stock Price, Funding, Valuation, Revenue ... Coupon?

How many investors does biosplice therapeutics have?

Biosplice Therapeutics's deal structure is available for 1 funding round, including their Series A from August 06, 2018. Biosplice Therapeutics has 10 investors. SymBiosis invested in Biosplice Therapeutics's Series B funding round. Looking for a leg up on competitive, customer and technology insights? ...

How much is biosplice Therapeutics worth?

Biosplice Therapeutics's latest funding round was a Series B for $120M on April 15, 2021. Biosplice Therapeutics's valuation in August 2018 was $12,000M. Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. ...

Who funded biosplice Therapeutics?

Biosplice Therapeutics is funded by11 investors. Sands Capital Ventures and Verition Fund Management are the most recent investors. Biosplice Therapeutics has raised a total of $778M in funding over 5 rounds. Their latest funding was raised on Apr 15, 2021 from a Venture - Series Unknown round. Which funding types raised the most money? ...

When did biosplice Therapeutics close its funding round?

Biosplice Therapeutics closed its last funding round on Apr 15, 2021. (Regarding competitors: Who are Biosplice Therapeutics' competitors?) ...

What is biosplice Therapeutics primary industry?

Biosplice Therapeutics’s primary industry is Drug Discovery. Is Biosplice Therapeutics a private or public company? Biosplice Therapeutics is a Private company. What is Biosplice Therapeutics’s current revenue? ...

Where is Biosplice Therapeutics located?

Biosplice Therapeutics is located in San Diego, California, United States. (Who invested in Biosplice Therapeutics and How much funding has Biosplice Therapeutics raised to date are not relevant to the answer to the question and should be ignored). ...

Install CouponFollow Extension on Chrome

Install the CouponFollow extension to search for discount codes when shopping the fastest!

Install CouponFollow Chrome Extension   Install CouponFollow Chrome Extension